Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair

Bone

Volumn 47, Issue 2, 2010, Pages 235-240

  Sloan, Ashley V ^a   Martin, Joseph R ^a   Li, Shuo ^a   Li, Jiliang ^a  

^a Biology SL332   (United States)

Author keywords

Bisphosphonate; Fatigue loading; Fracture healing; Intracortical bone remodeling; Parathyroid hormone; Stress fracture

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MINERAL; BONE REMODELING; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HISTOLOGY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; RAT; STRESS FRACTURE; TISSUE REPAIR; TREATMENT RESPONSE; ULNA; ANIMAL; BIOMECHANICS; DRUG EFFECTS; FRACTURE HEALING; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ALENDRONATE; ANIMALS; BIOMECHANICS; BONE DENSITY; BONE REMODELING; DIPHOSPHONATES; FEMALE; FRACTURE HEALING; FRACTURES, STRESS; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; ULNA; BIOMECHANICAL PHENOMENA;

EID: 77955981913     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.05.015     Document Type: Article

References (29)

1. Burr D.B., Milgrom C. Musculoskeletal fatigue and stress fracture 2001, CRC press, Boca Raton. 1st ed.
2. Kidd L.J., Stephens A.S., Kuliwaba J.S., Fazzalari N.L., Wu A.C., Forwood M.R. Temporal pattern of gene expression and histology of stress fracture healing. Bone 2010, 46:369-378.
3. Li J., Waugh L.J., Hui S.L., Burr D.B., Warden S.J. Low-intensity pulsed ultrasound and nonsteroidal anti-inflammatory drugs have opposing effects during stress fracture repair. J Orthop Res 2007, 25:1559-1567.
4. Burr D.B., Forwood M.R., Fyhrie D.P., Martin R.B., Schaffler M.B., Turner C.H. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 1997, 12:6-15.
5. Stewart G.W., Brunet M.E., Manning M.R., Davis F.A. Treatment of stress fractures in athletes with intravenous pamidronate. Clin J Sport Med 2005, 15:92-94.
6. Milgrom C., Finestone A., Novack V., Pereg D., Goldich Y., Kreiss Y., et al. The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits. Bone 2004, 35:418-424.
7. Alkhiary Y.M., Gerstenfeld L.C., Krall E., Westmore M., Sato M., Mitlak B.H., et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 2005, 87:731-741.
8. Andreassen T.T., Willick G.E., Morley P., Whitfield J.F. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 2004, 74:351-356.
9. Kakar S., Einhorn T.A., Vora S., Miara L.J., Hon G., Wigner N.A., et al. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 2007, 22:1903-1912.
10. Nakajima A., Shimoji N., Shiomi K., Shimizu S., Moriya H., Einhorn T.A., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002, 17:2038-2047.
11. Lindsay R., Zhou H., Cosman F., Nieves J., Dempster D.W., Hodsman A.B. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium. J Bone Miner Res 2007, 22:495-502.
12. Burr D.B., Hirano T., Turner C.H., Hotchkiss C., Brommage R., Hock J.M. Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys. J Bone Miner Res 2001, 16:157-165.
13. Hirano T., Burr D.B., Turner C.H., Sato M., Cain R.L., Hock J.M. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 1999, 14:536-545.
14. Chavassieux P.M., Arlot M.E., Roux J.P., Portero N., Daifotis A., Yates A.J., et al. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies. J Bone Miner Res 2000, 15:754-762.
15. Bentolila V., Boyce T.M., Fyhrie D.P., Drumb R., Skerry T.M., Schaffler M.B. Intracortical remodeling in adult rat long bones after fatigue loading. Bone 1998, 23:275-281.
16. Li J., Miller M.A., Hutchins G.D., Burr D.B. Imaging bone microdamage in vivo with positron emission tomography. Bone 2005, 37:819-824.
17. Verborgt O., Gibson G.J., Schaffler M.B. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res 2000, 15:60-67.
18. Sato M., Vahle J., Schmidt A., Westmore M., Smith S., Rowley E., et al. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology 2002, 143:3230-3242.
19. Follet H., Li J., Phipps R.J., Hui S., Condon K., Burr D.B. Risedronate and alendronate suppress osteocyte apoptosis following cyclic fatigue loading. Bone 2007, 40:1172-1177.
20. Turner C.H., Burr D.B. Basic biomechanical measurements of bone: a tutorial. Bone 1993, 14:595-608.
21. Li J., Mori S., Kaji Y., Mashiba T., Kawanishi J., Norimatsu H. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J Bone Miner Res 1999, 14:969-979.
22. Mashiba T., Burr D.B., Turner C.H., Sato M., Cain R.L., Hock J.M. Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits. Bone 2001, 28:538-547.
23. Lotinun S., Evans G.L., Bronk J.T., Bolander M.E., Wronski T.J., Ritman E.L., et al. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties. J Bone Miner Res 2004, 19:1165-1171.
24. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
25. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007, 40:1434-1446.
26. Iwata K., Li J., Follet H., Phipps R.J., Burr D.B. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia. Bone 2006, 39:1053-1058.
27. Cardoso L., Herman B.C., Verborgt O., Laudier D., Majeska R.J., Schaffler M.B. Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 2009, 24:597-605.
28. Li C., Mori S., Li J., Kaji Y., Akiyama T., Kawanishi J., et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res 2001, 16:429-436.
29. Li J., Mori S., Kaji Y., Kawanishi J., Akiyama T., Norimatsu H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J Bone Miner Res 2000, 15:2042-2051.